Medical devices, healthcare technology and the business of care
510(k) clearance · K260098

ePM Series Patient Monitor (ePM 10/ePM 10A/ePM 10C/Guardian plus/ ePM 12/ePM 12A/ePM 12C / ePM 15/ePM 15A/ePM 15C /ePM 10M/ ePM 10MA/ ePM 10MC/ePM 12M/ ePM 12MA/ ePM 12MC/ePM 15M/ ePM 15MA/ ePM 15MC)

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Decision date May 20, 2026

FDA DECISIONK260098

What did the FDA decide?

FDA records K260098 as a 510(k) premarket notification, with a decision dated May 20, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
May 20, 2026

FDA source record

Regulatory record facts

Identifier
K260098
Regulatory pathway
510(k) premarket notification
Product code
MHX
Decision code
SESE
Decision date
May 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms).

Product code
MHX
FDA device class
2

FDA decision timeline

  1. K260098 received

    Application receipt date recorded by FDA.

  2. K260098 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MHX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records